全文获取类型
收费全文 | 4236篇 |
免费 | 242篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 89篇 |
妇产科学 | 120篇 |
基础医学 | 587篇 |
口腔科学 | 25篇 |
临床医学 | 426篇 |
内科学 | 1082篇 |
皮肤病学 | 161篇 |
神经病学 | 369篇 |
特种医学 | 164篇 |
外科学 | 447篇 |
综合类 | 15篇 |
预防医学 | 214篇 |
眼科学 | 66篇 |
药学 | 331篇 |
中国医学 | 6篇 |
肿瘤学 | 379篇 |
出版年
2023年 | 25篇 |
2022年 | 64篇 |
2021年 | 95篇 |
2020年 | 46篇 |
2019年 | 56篇 |
2018年 | 103篇 |
2017年 | 77篇 |
2016年 | 89篇 |
2015年 | 93篇 |
2014年 | 124篇 |
2013年 | 165篇 |
2012年 | 270篇 |
2011年 | 275篇 |
2010年 | 157篇 |
2009年 | 147篇 |
2008年 | 248篇 |
2007年 | 263篇 |
2006年 | 244篇 |
2005年 | 207篇 |
2004年 | 219篇 |
2003年 | 206篇 |
2002年 | 186篇 |
2001年 | 122篇 |
2000年 | 112篇 |
1999年 | 93篇 |
1998年 | 45篇 |
1997年 | 28篇 |
1996年 | 42篇 |
1995年 | 31篇 |
1994年 | 30篇 |
1993年 | 22篇 |
1992年 | 79篇 |
1991年 | 61篇 |
1990年 | 48篇 |
1989年 | 55篇 |
1988年 | 54篇 |
1987年 | 49篇 |
1986年 | 39篇 |
1985年 | 44篇 |
1984年 | 23篇 |
1983年 | 16篇 |
1982年 | 9篇 |
1981年 | 18篇 |
1980年 | 13篇 |
1979年 | 18篇 |
1978年 | 9篇 |
1976年 | 10篇 |
1974年 | 11篇 |
1973年 | 8篇 |
1945年 | 9篇 |
排序方式: 共有4502条查询结果,搜索用时 968 毫秒
1.
2.
3.
4.
Obesity and beta-blockers: influence of body fat on their kinetics and cardiovascular effects 总被引:2,自引:0,他引:2
F Galletti M L Fasano L A Ferrara A Groppi M Montagna M Mancini 《Journal of clinical pharmacology》1989,29(3):212-216
Beta-blockers are among the most widely used antihypertensive drugs. They differ from each other in regard to several factors such as: beta-agonist activity, beta 1-selectivity and solubility. Aim of this work was to evaluate the influence of obesity on the kinetics and the antihypertensive effect of two Beta-blockers with different solubility such as: the water-soluble, atenolol and the liposoluble, metoprolol. The study was carried out according to an open randomized cross-over design. Eight obese hypertensive patients, after a two week washout period, were randomly allocated to a four week treatment. After a two week intermediate washout period, each patient switched to the other treatment for an additional four week period. On the first and the last day of each treatment the subjects were hospitalized to collect blood samples for the assay of the two drugs and to measure cardiovascular parameters. Obesity does not exert any effect on the kinetics of the water-soluble beta-blocker, atenolol, while markedly interferes with that of the liposoluble, without any apparent influence on its anti-hypertensive effect. These findings extend to obese hypertensives the concept that the plasma concentrations of beta-blocking agents are not reliable predictors of their therapeutic effect. 相似文献
5.
6.
Carmela Green-Abate 《Bulletin of the World Health Organization》1986,64(5):711-714
Birthweight data for 29 586 infants born in health-care facilities in Addis Ababa in 1973 and 1982 indicate that 40-60% of all deliveries took place within the formal health-care system. The mean birthweight increased by 107 g from 3075 ± 585 g in 1973 to 3181 ± 550 g in 1982. This increase was uniform over the entire birthweight range but was statistically significant only for infants of low birthweight, the frequency of such births decreasing from 13% to 8% over the period. Stratification of the data by sex indicated a similar increase in birthweight. The stillbirth rate decreased from 51.1 per 1000 births in 1973 to 34.1 per 1000 in 1982, but was statistically significant only for birthweights in the range 3000-4000 g. The shift in birthweight distribution reported here may reflect either changes in the demographic characteristics of the population or unidentified changes in medical treatment. 相似文献
7.
B E Ferrara 《Southern medical journal》1991,84(12):1487-1492
8.
Monica Conciatori Christopher J Stodgell Susan L Hyman Melanie O'Bara Roberto Militerni Carmela Bravaccio Simona Trillo Francesco Montecchi Cindy Schneider Raun Melmed Maurizio Elia Lori Crawford Sarah J Spence Lucianna Muscarella Vito Guarnieri Leonardo D'Agruma Alessandro Quattrone Leopoldo Zelante Daniel Rabinowitz Tiziana Pascucci Stefano Puglisi-Allegra Karl-Ludvig Reichelt Patricia M Rodier Antonio M Persico 《Neuropsychopharmacology》2004,55(4):413-419
BACKGROUND: The HOXA1 gene plays a major role in brainstem and cranial morphogenesis. The G allele of the HOXA1 A218G polymorphism has been previously found associated with autism. METHODS: We performed case-control and family-based association analyses, contrasting 127 autistic patients with 174 ethnically matched controls, and assessing for allelic transmission disequilibrium in 189 complete trios. RESULTS: A, and not G, alleles were associated with autism using both case-control (chi(2) = 8.96 and 5.71, 1 df, p <.005 and <.025 for genotypes and alleles, respectively), and family-based (transmission/disequilibrium test chi(2) = 8.80, 1 df, p <.005) association analyses. The head circumference of 31 patients carrying one or two copies of the G allele displayed significantly larger median values (95.0th vs. 82.5th percentile, p <.05) and dramatically reduced interindividual variability (p <.0001), compared with 166 patients carrying the A/A genotype. CONCLUSIONS: The HOXA1 A218G polymorphism explains approximately 5% of the variance in the head circumference of autistic patients and represents to our knowledge the first known gene variant providing sizable contributions to cranial morphology. The disease specificity of this finding is currently being investigated. Nonreplications in genetic linkage/association studies could partly stem from the dyshomogeneous distribution of an endophenotype morphologically defined by cranial circumference. 相似文献
9.
10.
Carmine Zoccali Renke Maas Sebastiano Cutrupi Patrizia Pizzini Piero Finocchiaro Francesco Cambareri Vincenzo Panuccio Carmela Martorano Friedrich Schulze Giuseppe Enia Giovanni Tripepi Rainer Boger 《Nephrology, dialysis, transplantation》2007,22(3):801-806
BACKGROUND AND METHODS: The endogenous inhibitor of nitric oxide synthase (NOs) asymmetrical dimethyl-arginine (ADMA) has been implicated as a possible modulator of inducible NOs during acute inflammation. We examined the evolution in the plasma concentration of ADMA measured at the clinical outset of acute inflammation and after its resolution in a series of 17 patients with acute bacterial infections. RESULTS: During the acute phase of inflammation/infection, patients displayed very high levels of C-reactive protein (CRP), interleukin-6 (IL-6), procalcitonin and nitrotyrosine. Simultaneous plasma ADMA concentration was similar to that in healthy subjects while symmetric dimethyl-arginine (SDMA) levels were substantially increased and directly related with creatinine. When infection resolved, ADMA rose from 0.62 +/- 0.23 to 0.80 +/- 0.18 micromol/l (+29%, P = 0.01) while SDMA remained unmodified. ADMA changes were independent on concomitant risk factor changes and inversely related with baseline systolic and diastolic pressure. Changes in the ADMA/SDMA ratio were compatible with the hypothesis that inflammatory cytokines activate ADMA degradation. CONCLUSIONS: Resolution of acute inflammation is characterized by an increase in the plasma concentration of ADMA. The results imply that ADMA suppression may actually serve to stimulate NO synthesis or that in this situation plasma ADMA levels may not reflect the inhibitory potential of this methylarginine at the cellular level. 相似文献